Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances of imidazole-containing derivatives as anti-tubercular agents
Yilei Fan, Xiaohong Jin, Zhongping Huang, et al.
European Journal of Medicinal Chemistry (2018) Vol. 150, pp. 347-365
Closed Access | Times Cited: 138

Showing 26-50 of 138 citing articles:

Azoalkyl ether imidazo[2,1-b]benzothiazoles as potentially antimicrobial agents with novel structural skeleton
Swetha Kameswari Maddili, Zhenzhen Li, Vijaya Kumar Kannekanti, et al.
Bioorganic & Medicinal Chemistry Letters (2018) Vol. 28, Iss. 14, pp. 2426-2431
Closed Access | Times Cited: 48
Gold‐Catalyzed Oxidation of Internal Alkynes into Benzils and its Application for One‐Pot Synthesis of Five‐, Six‐, and Seven‐Membered Azaheterocycles
Alexey Yu. Dubovtsev, Dmitry Dar’in, Mikhail Krasavin, et al.
European Journal of Organic Chemistry (2019) Vol. 2019, Iss. 8, pp. 1856-1864
Closed Access | Times Cited: 48
Design, synthesis and antibacterial activity evaluation of moxifloxacin-amide-1,2,3-triazole-isatin hybrids
Feng Gao, Lei Ye, Fangong Kong, et al.
Bioorganic Chemistry (2019) Vol. 91, pp. 103162-103162
Closed Access | Times Cited: 47
Bis -(Imidazole/Benzimidazole)-Pyridine Derivatives: Synthesis, Structure and Antimycobacterial Activity
Vasilichia Antoci, Dumitrela Diaconu, Gheorghiță Zbancioc, et al.
Future Medicinal Chemistry (2020) Vol. 12, Iss. 3, pp. 207-222
Open Access | Times Cited: 42
Design, synthesis, antimicrobial evaluation and docking studies of urea-triazole-amide hybrids
Kashmiri Lal, Nisha Poonia, Poonam Rani, et al.
Journal of Molecular Structure (2020) Vol. 1215, pp. 128234-128234
Closed Access | Times Cited: 39
An insight into the medicinal perspective of synthetic analogs of imidazole
Sandeep Rulhania, Shubham Kumar, Bhupender Nehra, et al.
Journal of Molecular Structure (2021) Vol. 1232, pp. 129982-129982
Closed Access | Times Cited: 35
Recent advancements and developments in search of anti-tuberculosis agents: A quinquennial update and future directions
Tejas M. Dhameliya, Kaushikkumar A. Bhakhar, Normi D. Gajjar, et al.
Journal of Molecular Structure (2021) Vol. 1248, pp. 131473-131473
Closed Access | Times Cited: 32
Benzoxazine: A Privileged Scaffold in Medicinal Chemistry
Zilong Tang, Yuhuan Tan, Hongjuan Chen, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 4, pp. 372-389
Closed Access | Times Cited: 25
Artificial Intelligence in Drug Discovery and Development Against Antimicrobial Resistance: A Narrative Review
Mustafa Ghaderzadeh, Armin Shalchian, Gholamreza Irajian, et al.
Iranian Journal of Medical Microbiology (2024) Vol. 18, Iss. 3, pp. 135-147
Open Access | Times Cited: 3
Synthesis, biological activities and docking studies of piperazine incorporated 1, 3, 4-oxadiazole derivatives
Shipra Bhati, Vijay Kumar, Joginder Singh, et al.
Journal of Molecular Structure (2019) Vol. 1191, pp. 197-205
Closed Access | Times Cited: 41
Current and promising novel drug candidates against visceral leishmaniasis
Rosa M. Reguera, Yolanda Pérez‐Pertejo, Camino Gutiérrez-Corbo, et al.
Pure and Applied Chemistry (2019) Vol. 91, Iss. 8, pp. 1385-1404
Open Access | Times Cited: 41
Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus
Adetomiwa A. Adeniji, Kirsten E. Knoll, Du Toit Loots
Applied Microbiology and Biotechnology (2020) Vol. 104, Iss. 13, pp. 5633-5662
Closed Access | Times Cited: 33
N-Benzoylthiourea-pyrrolidine carboxylic acid derivatives bearing an imidazole moiety: Synthesis, characterization, crystal structure, in vitro ChEs inhibition, and antituberculosis, antibacterial, antifungal studies
Samet Poyraz, H. Ali Döndaş, José M. Sansano, et al.
Journal of Molecular Structure (2022) Vol. 1273, pp. 134303-134303
Open Access | Times Cited: 18
Construction of graphene quantum dot-based dissolving microneedle patches for the treatment of bacterial keratitis
Yirong Fang, Zhuo Lin, Hang Yuan, et al.
International Journal of Pharmaceutics (2023) Vol. 639, pp. 122945-122945
Closed Access | Times Cited: 10
Libraries of C‐5 Substituted Imidazoles and Oxazoles by Sequential Van Leusen (VL)–Suzuki, VL–Heck and VL–Sonogashira in Imidazolium‐ILs with Piperidine‐Appended‐IL as Base
Hemantkumar M. Savanur, Rajesh G. Kalkhambkar, Kenneth K. Laali
European Journal of Organic Chemistry (2018) Vol. 2018, Iss. 38, pp. 5285-5288
Closed Access | Times Cited: 37
Synthesis, characterization and biological activities of imidazo[1,2-a]pyridine based gold(III) metal complexes
Darshana A. Kanthecha, Bhupesh S. Bhatt, Mohan N. Patel
Heliyon (2019) Vol. 5, Iss. 6, pp. e01968-e01968
Open Access | Times Cited: 30
Nitroimidazole-containing compounds and their antibacterial and antitubercular activities
Jingyu Zhang, Yanyan Ba, Su Wang, et al.
European Journal of Medicinal Chemistry (2019) Vol. 179, pp. 376-388
Closed Access | Times Cited: 30
Contemporary Progress in the Synthetic Strategies of Imidazole and its Biological Activities
Jay Soni, Ayushi Sethiya, Nusrat Sahiba, et al.
Current Organic Synthesis (2019) Vol. 16, Iss. 8, pp. 1078-1104
Closed Access | Times Cited: 30
Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization – Insight from DFT calculations, molecular docking and molecular dynamics simulations
Olayinka I. Akinpelu, Monsurat M. Lawal, Hezekiel M. Kumalo, et al.
Tuberculosis (2020) Vol. 121, pp. 101920-101920
Closed Access | Times Cited: 28
Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis
Adinarayana Nandikolla, Singireddi Srinivasarao, Yogesh Mahadu Khetmalis, et al.
Toxicology in Vitro (2021) Vol. 74, pp. 105137-105137
Closed Access | Times Cited: 23
Design and synthesis of new N-thioacylated ciprofloxacin derivatives as urease inhibitors with potential antibacterial activity
Keyvan Pedrood, Homa Azizian, Mohammad Nazari Montazer, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Expedited Synthesis and Comprehensive Characterization of Oxomorpholine-Imidazole Derivatives: Unraveling their Remarkable Antimicrobial Activity
Sachin M. Sitapara, Jignesh H. Pandya, Shantaben K. Kangad
Journal of Scientific Research (2024) Vol. 16, Iss. 1, pp. 321-330
Open Access | Times Cited: 2
Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis
Mikhail Krasavin, Alexei Lukin, Tatiana Vedekhina, et al.
European Journal of Medicinal Chemistry (2018) Vol. 157, pp. 1115-1126
Closed Access | Times Cited: 27
Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation
Rongxing Chen, Hao Zhang, Tianwei Ma, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 18, pp. 2635-2637
Closed Access | Times Cited: 27
Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents
Tilal Elsaman, Malik Suliman Mohamed, Magdi Awadalla Mohamed
Bioorganic Chemistry (2019) Vol. 88, pp. 102969-102969
Closed Access | Times Cited: 26

Scroll to top